Jerusalem Pharmaceuticals Co. Ltd. reported unaudited consolidated earnings results for the nine months ended September 30, 2014. For the nine months period, the company reported net profit after taxes of USD 1,033,909 compared with a net profit after taxes of USD 1,609,305 from the first nine months of 2013, a net decrease of 35.8%.

Net ownership equity of the company reached USD 36,349,920 (including USD 508,054 non-controlling interest) as of September 30th, 2014, compared with net ownership equity of USD 37,683,265 (including USD 705,854 non-controlling interest) as of December 31st, 2013, a net decrease of 3.5% in the first nine months.